Indaptus Therapeutics (INDP) Other financing activities (2021)
Indaptus Therapeutics (INDP) posted quarterly Other financing activities of $182000.0 for Q4 2021, up 119.6% quarter-over-quarter from -$928727.0 in Q3 2021.
Indaptus Therapeutics (INDP) Other financing activities (2021) Analysis & Trends
Indaptus Therapeutics' Other financing activities history runs 1 years deep, the most recent figure standing at $182000.0 for Q4 2021.
- In Q4 2021, Other financing activities changed N/A year-over-year to $182000.0; the TTM figure through Dec 2021 stood at $209273.0 (changed N/A YoY), while the FY2021 annual figure was $27273.0, changed N/A from the prior year.
- Other financing activities for Q4 2021 stood at $182000.0, up from -$928727.0 in the prior quarter.
- The five-year high for Other financing activities was $956000.0 in Q1 2021, with the low at -$928727.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Indaptus Therapeutics | 147.49 Mn | 135.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 182,000.00 |
| Dec 31, 2021 | 182,000.00 |
| Sep 30, 2021 | -928,727.00 |
| Sep 30, 2021 | -928,727.00 |
| Mar 31, 2021 | 956,000.00 |
| Mar 31, 2021 | 956,000.00 |